Evidence map›Paper›PMID 39717527›Full record

ArticleIntelligence-based medicine2024

Estimating the prevalence of diabetic retinopathy in electronic health records with massive missing labels.

Ye Liang, Ru Wang, Yuchen Wang, Tieming Liu

Abstract read
In one paragraph

Article in Intelligence-based medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ye LiangDepartment of Statistics, Oklahoma State University, Stillwater, OK, USA.
Ru WangDell Technologies, Round Rock, TX, USA.
Yuchen WangCollege of Management, University of Massachusetts Boston, Boston, MA, USA.
Tieming LiuSchool of Industrial Engineering and Management, Oklahoma State University, Stillwater, OK, USA.

Funding

SCH: Harnessing Tensor Information to Improve EHR Data Quality for Accurate Data-driven Screening of Diabetic Retinopathy with Routine Lab ResultsR01EY033861 · NEI · OKLAHOMA STATE UNIVERSITY STILLWATER · PI LIU, TIEMING · 2021 to 2025
$1.5M
NEI NIH HHS R01 EY033861
6 · The paper itself

Abstract

Objective: The paper aims to address the problem of massive unlabeled patients in electronic health records (EHR) who potentially have undiagnosed diabetic retinopathy (DR). It is desired to estimate the actual DR prevalence in EHR with 96 % missing labels. Materials and methods: The Cerner Health Facts data are used in the study, with 3749 labeled DR patients and 97,876 unlabeled diabetic patients. This extensive dataset spans the demographics of the United States over the past two decades. We implemented state-of-art positive-unlabeled learning methods, including ensemble-based support vector machine, ensemble-based random forest, and Bayesian finite mixture modeling. Results: The estimated DR prevalence in the population represented by Cerner EHR is approximately 25 % and the classification techniques generally achieve an AUC of around 87 %. As a by-product, a predictive inference on the risk of DR based on a patient's personalized medical information is derived. Discussion: Missing labels is a common issue for EHR data quality. Ignoring these missing labels can lead to biased results in the analyses of EHR data. The problem is especially severe in the context of DR. It is thus important to use machine learning or statistical tools to identify the unlabeled patients. The tool in this paper helps both data analysts and clinicians in their practices.

Indexed as

Bayesian mixture modelsClassificationDiabetic retinopathyMachine learningPositive-unlabeled learningPredictive inference

Identifiers

PMID39717527
PMCPMC11666125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.